Logashvari Naidoo

2.2k total citations · 1 hit paper
9 papers, 106 citations indexed

About

Logashvari Naidoo is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Logashvari Naidoo has authored 9 papers receiving a total of 106 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Epidemiology and 4 papers in General Health Professions. Recurrent topics in Logashvari Naidoo's work include HIV/AIDS Research and Interventions (6 papers), HIV, Drug Use, Sexual Risk (4 papers) and Adolescent Sexual and Reproductive Health (4 papers). Logashvari Naidoo is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), HIV, Drug Use, Sexual Risk (4 papers) and Adolescent Sexual and Reproductive Health (4 papers). Logashvari Naidoo collaborates with scholars based in South Africa, Uganda and United States. Logashvari Naidoo's co-authors include Elizabeth R. Brown, Thesla Palanee‐Phillips, Krishnaveni Reddy, Flavia Matovu Kiweewa, Jared M. Baeten, Lydia Soto‐Torres, Samantha Siva, Arendevi Pather, Sarah T. Roberts and Kristine Torjesen and has published in prestigious journals such as Nature Medicine, JNCI Journal of the National Cancer Institute and The Lancet Infectious Diseases.

In The Last Decade

Logashvari Naidoo

7 papers receiving 106 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial

2024 47 citations Cissy Kityo, Ivan Mambule et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Logashvari Naidoo South Africa	4	98	42	41	36	14	9	106
Lillian Okui United States	6	81 0.8×	35 0.8×	44 1.1×	59 1.6×	7 0.5×	8	116
Fodié Diallo Mali	7	96 1.0×	74 1.8×	24 0.6×	38 1.1×	3 0.2×	16	142
John Steytler United States	4	84 0.9×	36 0.9×	39 1.0×	37 1.0×	12 0.9×	8	109
Justice Quame‐Amaglo United States	7	162 1.7×	92 2.2×	51 1.2×	70 1.9×	3 0.2×	9	181
John W. Mellors United States	4	51 0.5×	47 1.1×	27 0.7×	40 1.1×	10 0.7×	5	95
Jeremy Chow United States	6	81 0.8×	34 0.8×	26 0.6×	72 2.0×	16 1.1×	26	156
Fredrick Owino Kenya	5	136 1.4×	20 0.5×	94 2.3×	62 1.7×	15 1.1×	10	171
Ishana Harkoo South Africa	6	88 0.9×	27 0.6×	39 1.0×	49 1.4×	13 0.9×	14	107
Rachel Scheckter United States	7	93 0.9×	18 0.4×	50 1.2×	69 1.9×	11 0.8×	17	123
Samantha Siva South Africa	5	140 1.4×	20 0.5×	112 2.7×	66 1.8×	23 1.6×	16	161

Countries citing papers authored by Logashvari Naidoo

Since Specialization

Citations

This map shows the geographic impact of Logashvari Naidoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Logashvari Naidoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Logashvari Naidoo more than expected).

Fields of papers citing papers by Logashvari Naidoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Logashvari Naidoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Logashvari Naidoo. The network helps show where Logashvari Naidoo may publish in the future.

Co-authorship network of co-authors of Logashvari Naidoo

This figure shows the co-authorship network connecting the top 25 collaborators of Logashvari Naidoo. A scholar is included among the top collaborators of Logashvari Naidoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Logashvari Naidoo. Logashvari Naidoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Kityo, Cissy, Ivan Mambule, Simiso Sokhela, et al.. (2025). Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial. Nature Medicine. 32(1). 168–177.

2.

Brown, Elizabeth R., Stephen Cherne, Ailton Sepulveda, et al.. (2025). Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE. JNCI Journal of the National Cancer Institute. 118(3). 485–491.

3.

Kityo, Cissy, Ivan Mambule, Simiso Sokhela, et al.. (2024). Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial. The Lancet Infectious Diseases. 24(10). 1083–1092. 47 indexed citations breakdown →

4.

Browne, Erica N., Kristine Torjesen, Brenda Gati Mirembe, et al.. (2023). Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex. AIDS Care. 36(1). 80–86. 3 indexed citations

5.

Browne, Erica N., Elizabeth R. Brown, Thesla Palanee‐Phillips, et al.. (2022). Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 90(4). 418–424. 3 indexed citations

6.

Reddy, Krishnaveni, Elizabeth R. Brown, Nitesha Jeenarain, et al.. (2019). Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities. AIDS. 34(4). 559–567. 3 indexed citations

7.

Palanee‐Phillips, Thesla, Sarah T. Roberts, Krishnaveni Reddy, et al.. (2018). Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 79(5). 580–589. 33 indexed citations

8.

Balkus, Jennifer E., Thesla Palanee‐Phillips, Krishnaveni Reddy, et al.. (2017). Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception. JAIDS Journal of Acquired Immune Deficiency Syndromes. 76(2). e47–e51. 15 indexed citations

9.

Palanee‐Phillips, Thesla, Sarah T. Roberts, Elizabeth Montgomery, et al.. (2016). Frequency of Partner-related Social Harms and their Impact on Adherence to the Dapivirine Vaginal Ring during the MTN020/ASPIRE HIV Prevention Trial. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact